Mehta J, Iacona M, Pepine C J, Conti C R
Br Heart J. 1979 Dec;42(6):664-70. doi: 10.1136/hrt.42.6.664.
The haemodynamic effects of oral prazosin and hydralazine were evaluated in patients with refractory heart failure and compared with those of intravenous nitroprusside in the same patients. Both oral agents were well tolerated and appeared to have beneficial haemodynamic effects. Prazosin and hydralazine produced similar increases in cardiac output associated with a similar decrease in systemic vascular resistance. Prazosin and hydralazine produced similar increases in cardiac output associated with a similar decrease in systemic vascular resistance. Prazosin resulted in a more significant decline in left ventricular filling pressure and pulmonary vascular resistance than did hydralazine. Haemodynamic alterations induced by prazosin were similar to those induced by nitroprusside, which suggests a relatively balanced reduction of preload and afterload. With hydralazine, the increase in cardiac output without change in left ventricular filling pressure or pulmonary vascular resistance suggests minimal effect on preload but significant reduction in afterload.
对难治性心力衰竭患者评估了口服哌唑嗪和肼屈嗪的血流动力学效应,并与同一患者静脉注射硝普钠的效应进行比较。两种口服药物耐受性良好,似乎具有有益的血流动力学效应。哌唑嗪和肼屈嗪使心输出量有相似增加,同时全身血管阻力有相似降低。哌唑嗪导致左心室充盈压和肺血管阻力的下降比肼屈嗪更显著。哌唑嗪引起的血流动力学改变与硝普钠引起的相似,这表明前负荷和后负荷得到了相对平衡的降低。使用肼屈嗪时,心输出量增加而左心室充盈压或肺血管阻力无变化,这表明对前负荷影响极小,但后负荷显著降低。